Skip to content
value.today

Celularity Inc. vs IGC Pharma, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • IGC Pharma, Inc. is the larger company by market value: $29 M against $28 M for Celularity Inc., 1.1 times as much (market caps of Oct 30, 2026 for Celularity Inc. and Oct 26, 2026 for IGC Pharma, Inc.).
  • Celularity Inc. had more revenue: $27 M in the year to December 2025 against $1 M for IGC Pharma, Inc. in the year to March 2025.
  • Both made a net loss: $92 M for Celularity Inc. and $7 M for IGC Pharma, Inc.
  • Celularity Inc. keeps more of each dollar of sales: a net margin of -345.5% against -560.6% for IGC Pharma, Inc.

Market cap history

$0 M$153 M$307 M$460 M$613 M2023202420252026
● Celularity Inc.● IGC Pharma, Inc.

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B201720182019202020212022202320242025Celularity Inc. $0BIGC Pharma, Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureCelularity Inc.
CELU · #23,307 in the world
IGC Pharma, Inc.
IGC · #23,120 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded——
Size
Market cap$28 M$29 M
Revenue$27 M$1 M
Net income$-92 M$-7 M▲ best
Employees288—
Valuation
Price to sales1.5×24.9×
Price to book—3.9×
Free cash flow yield-23.8%-16.8%▲ best
Profitability
Gross margin24.4%—
Operating margin-230.9%—
Net margin-345.5%—
Growth
Revenue growth-51.0%—
Revenue growth, 3 years a year13.9%—
Financial strength
Debt to equity—0.0×
Altman Z-score zonedistress—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Oct 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Celularity Inc. or IGC Pharma, Inc.?

IGC Pharma, Inc. is the larger company by market value: $29 M against $28 M for Celularity Inc., 1.1 times as much (market caps of Oct 30, 2026 for Celularity Inc. and Oct 26, 2026 for IGC Pharma, Inc.).

Which makes more money, Celularity Inc. or IGC Pharma, Inc.?

Celularity Inc. had more revenue: $27 M in the year to December 2025 against $1 M for IGC Pharma, Inc. in the year to March 2025. Both made a net loss: $92 M for Celularity Inc. and $7 M for IGC Pharma, Inc.

Which is more profitable, Celularity Inc. or IGC Pharma, Inc.?

Celularity Inc. keeps more of each dollar of sales: a net margin of -345.5% against -560.6% for IGC Pharma, Inc.

Sources#

Every figure on this page comes from these, with the date shown next to it.